Clinical Trial Update: Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease [Phase 2]

View source ↗

Summary

Phase II trial results evaluating the safety and efficacy of a Heart Polypill for primary prevention of cardiovascular disease have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hyperlipidemia
• Hypertension

Drugs mentioned

• Heart Polypill (Fixed-dose combination polypill)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cardiovascular Disease, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2009-06-23